Related Experiment Video
Updated: Jul 13, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Association analysis of tyrosine kinase FYN gene polymorphisms in asthmatic children
Aleksandra Szczepankiewicz1, Anna Breborowicz, Maria Skibińska
1Department of Pediatric Pulmonology, Allergy and Clinical Immunology, Poznan University of Medical Sciences, Poznan, Poland. alszczep@amp.edu.pl
Background:
FYN is nonreceptor tyrosine kinase that represents the earliest detectable signaling response after antigen-activated inflammatory cells. Studies in animal models of allergic asthma have shown that inhibitors of tyrosine kinases exert an anti-inflammatory effect. In the FYN gene, several polymorphisms have been described. There have, however, been no studies analyzing the impact of FYN gene polymorphisms on the course and severity of asthma. The aim of this study was to analyze the possible relationship between three polymorphisms (-93A/G, Intron10+37C/T and Ex12+894T/G) in the FYN gene and asthma.
Methods:
We analyzed 120 pediatric asthmatic patients aged from 6 to 18 years. The diagnosis of allergic asthma was based on clinical manifestation, lung function test and positive skin prick tests and/or an increased IgE level. The control group consisted of 187 healthy subjects. The polymorphisms were genotyped with use of the PCR-RFLP method.
Results:
We observed an association of the -93A/G polymorphism and the presence of asthma (p = 0.014 for genotypes and p = 0.019 for alleles) and in the subgroup of 55 patients with severe asthma (p = 0.042 for genotypes and p = 0.021 for alleles). We also found an association of the Ex12+894T/G polymorphism in the whole group analyzed (p = 0.067 for genotypes and p = 0.024 for alleles), but not in the subgroup with severe asthma. For the Intron10+37T/C polymorphism, we did not find a significant difference between the whole group of asthmatic patients and the control group nor between the subgroup with severe asthma and the control group. In the linkage disequilibrium analysis, we observed a modest linkage between -93A/G and Intron10+37T/C polymorphisms (lod = 18.7, D' = 0.62, 95% CI: 0.51-0.71, r2 = 0.29); however, it was not strong enough to generate any haplotypes.
Conclusions:
The results may suggest a relationship between the FYN polymorphisms and allergic asthma.
Insights
Genetic variations in the FYN gene, specifically the -93A/G polymorphism, are associated with the presence and severity of allergic asthma in children. Further research may clarify the role of FYN gene polymorphisms in asthma development.
Area of Science:
- Immunogenetics
- Molecular Biology
- Respiratory Medicine
Background:
- FYN is a nonreceptor tyrosine kinase crucial in early inflammatory cell signaling.
- Tyrosine kinase inhibitors show anti-inflammatory effects in asthma models.
- Previous studies have not investigated FYN gene polymorphisms in relation to asthma.
Purpose of the Study:
- To investigate the association between three specific FYN gene polymorphisms (-93A/G, Intron10+37C/T, Ex12+894T/G) and allergic asthma.
- To determine if these polymorphisms correlate with asthma severity in pediatric patients.
Main Methods:
- Genotyping of 120 pediatric asthma patients (ages 6-18) and 187 healthy controls using PCR-RFLP.
- Asthma diagnosis confirmed by clinical presentation, lung function, skin prick tests, and IgE levels.
Main Results:
- The -93A/G polymorphism was significantly associated with asthma presence (p=0.014) and severe asthma (p=0.042).
- The Ex12+894T/G polymorphism showed association with asthma in the overall group (p=0.067) but not severe cases.
- No significant association was found for the Intron10+37T/C polymorphism.
Conclusions:
- FYN gene polymorphisms, particularly -93A/G, may be linked to allergic asthma.
- These findings suggest a potential genetic contribution of FYN to asthma pathogenesis.
- Further studies are warranted to elucidate the precise role of FYN in asthma.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
